Cancer-associated venous thromboembolism
Conditions
Interventions
None listed
Sponsors
Amsterdam UMC
Eligibility
Inclusion criteria
Inclusion criteria: - Adult patients (age >18 years) - Ambulatory setting - Histologically or cytologically confirmed cancer - Chemotherapy indicated within 3 months
Exclusion criteria
Exclusion criteria: - Desmoid tumors - Pre-stages of cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Venous thromboembolism in the 6 months following cancer diagnosis | — |
Secondary
| Measure | Time frame |
|---|---|
| - Venous thromboembolism in 12 months and longer follow-up periods after cancer diagnosis. - Venous thromboembolism in the 6 months, 12 months and longer follow-up periods after reactivation of cancer. - Arterial thromboembolism in 6 months, 12 months and longer follow-up periods after primary cancer diagnosis or reactivation of cancer. - Mortality in 6 months, 12 months, and longer follow-up periods after primary cancer diagnosis. | — |
Contacts
Public ContactFrits Mulder
Academic Medical Center
Outcome results
None listed